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Abstract
Background. The surgical treatment technique for liver hydatic cyst (LHC) cannot be standardized, and the surgical
technique should be tailored according to the extent of the cyst and any adjunct complications of hydatid disease. Patients
and methods. All patients were treated with albendazole (10 mg/kg/day) for 15 days preoperatively. Total pericystectomy was
performed in three patients (7%). Partial cystectomy and its modifications were performed in the remaining 41 patients
(93%). Results. A total of 44 patients were operated on for LHC between December 1998 and October 2004 in our center.
Patients were evaluated with ultrasonography and computed tomography scan to determine the extent of the disease and
preoperative staging. Twenty-four (53%) of these patients were women and 20 were men (median age, 52.5 years; range,
19/81 years). The majority of patients (n/27) had 1 cyst, and the remaining 17 patients had multiple cysts. In four
patients (9.1%), daughter cysts were found in the biliary system, and abscesses were present in three patients (7%). Biliary
fistula was the most frequent complication (n/5). Three patients had wound infections. Follow-up was complete for 33
patients (75%). The mean postoperative follow-up was 11.99/10.8 months; there were four recurrences during this time.
Discussion. The aim should be to provide complete drainage and obliteration of the cavity. Bile leak and biliary obstruction
may complicate the postoperative course if bile leakage into the peritoneal cavity and obstruction in the biliary system are
missed.
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Introduction
Hydatid disease has been known since the time of
Hippocrates and is described as a ‘liver full of water’.
The disease is endemic in the Mediterranean region,
South America, the Far East, the Middle East, and
Eastern Europe. However, it is being observed more
frequently in nonendemic countries owing to increas-
ing global travel [1].
Hydatid disease is a zoonosis caused mainly by
Echinococcus granulosus , or less frequently by Echino-
coccus multilocularis and Echinococcus oligarthrus . The
primary carriers are dogs and wolves. The intermedi-
ate hosts are sheep, cattle, and deer. Humans are
alternative/accidental secondary hosts and are in-
fected by ingestion of ova from the feces of dogs [2].
Early diagnosis is important, as if the diagnosis is late,
cysts are complicated and the treatment is difficult
and long-lasting [3]. The most effective treatment of
noncomplicated hydatid disease is evacuation of the
cyst fluid and decreasing the dead space of the cystic
cavity. However, if the cysts are complicated, there is
no standard management of treatment [4]. In this
latter scenario, treatment is determined according to
the stage of the cyst and the relation of the cyst to the
biliary ducts or surrounding organs.
In this study, we present the treatment of hydatid
disease patients at our clinic and discuss the indica-
tions and efficacy of surgical treatment.
Patients and methods
In our hospital, 84 patients with hydatid disease
were treated between December 1998 and October
2004; 44 of the patients were treated surgically, and
the rest were treated with radiologic intervention.
Each patient’s medical record was reviewed retro-
spectively for results of the physical examination,
serum biochemistry, abdominal ultrasound (US),
and spiral abdominal computed tomography (CT)
or magnetic resonance imaging (MRI) scans. The
Gharbi classification system was used to stage the
hydatid disease [5].
Surgical treatment was used for all cysts that
were larger than 15 cm, those that were complicated,
and those that were not suitable for interventional
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radiology (type III or IV). All patients were treated
with albendazole (10 mg/kg) 15 days before surgery,
and this medication was continued for 2 months
postoperatively. Magnetic resonance cholangio-
pancreatography (MRCP) or endoscopic retrograde
cholangio-pancreatography (ERCP) also were used
preoperatively for patients with jaundice, history of
cholangitis, dilatation of the biliary ducts, existence of
debris in the bile ducts, or elevation of serum liver
transaminases.
Surgical treatment
A 20% hypertonic saline solution was used to
deactivate the cyst content. Prior to injection of this
solution into the cystic cavity, the contents of the cyst
were completely aspirated to prevent dilution of
the agent. The solution was left inside the cyst about
10 min to kill the scolices. To prevent accidental
spillage of the cystic contents, the puncture site was
covered with hypertonic saline solution-soaked
gauzes. If the cyst was localized to the liver periphery,
the entire cyst could be excised; however, if the cysts
were centrally located, they were drained through a
hepatotomy. After evacuating the cystic contents, the
cavity was explored for any possible communication
with the bile duct. The offending bile duct was then
sutured. The remaining cystic cavity was then drained
or obliterated. Obliteration was achieved with omen-
toplasty or capitonnage. A drain was then placed into
the subhepatic or subdiaphragmatic space. Explora-
tion of the main bile duct was performed in four
patients in whom preoperative ERCP drainage had
been unsuccessful.
Results
There were 20 (47%) male and 24 (53%) female
patients with a mean age of 52.5 years (range 19/
81 years). There was 1 cyst in 27 patients (61%),
and there were 2 cysts in 7 patients (17%), 3 cysts in
5 patients (11%), 4 cysts in 1 patient (2%), and more
than 4 cysts in 4 patients (9%). The number of
preoperative diagnostic tools is shown in Table I.
Distribution of patients according to Gharbi classifi-
cation is shown in Table II.
Surgical treatment was performed in six patients
who had been treated percutaneously and then
experienced recurrence. An anaphylactic reaction
was reported to occur in one patient while undergo-
ing percutaneous drainage in another center. The
treatment for that anaphylaxis was unclear from the
previous medical history. However, the patient was in
good health when she was admitted to our center. She
had an uneventful postoperative course. Two patients
had urgent operations. Both of them had high fever,
leucocytosis, jaundice and clinical examination find-
ings suggesting free perforation. Upon exploration
free perforation of the infected type IV cyst was
confirmed for both patients. Drainage of the cyst
cavity and main bile duct exploration with T-tube
drainage was performed. Although wound infection
developed in one patient both of them were dis-
charged uneventfully. Splenectomy was performed in
two patients because of concomitant splenic hydatid
disease. A closed thorax drainage tube was placed in
one patient who had an injury to the diaphragm and
pleura due to a close relationship between the cyst and
the diaphragm. Three patients had disseminated
abdominal hydatidosis. Midline laparotomy incisions
were used for these patients. The cysts were situated
in every location of the abdominal cavitiy. Cystectomy
was done for the cysts that did not endanger the
nearby organs. Partial cystectomy and drainage were
performed for the rest of the cysts. Cholecystectomy
was performed in seven patients because three of
them had biliary stones and in four patients there was
a close relationship between the cyst and the gall
bladder.
Thirteen patients had communication between the
cysts and biliary tract. This communication was
detected in 10 of the 13 patients (77%) during sur-
gery and during preoperative evaluation in the
other 3. These communications were repaired pri-
marily. Complications were observed in 12 patients
(Table III). There was no operative mortality in this
series. Wound infections were treated by meticulous
wound care. A patient who had pelvic hydatidosis
developed deep venous thrombosis and was treated
conventionally with heparin infusion. Hypernatremia
Table I. Number of preoperative diagnostic tools.
Diagnostic tools Number (%)
US 16 (36%)
US/CT 24 (55%)
CT 3 (7%)
US/CT/MRI 1 (2%)
Total 44 (100%)
US, ultrasound; CT, computed tomography; MRI, magnetic
resonance imaging.
Table II. Type of cyst according to Gharbi classification.
Type of cyst Gharbi classification Number (%)
Type I Pure fluid collection 5 (12%)
Type II Fluid collection with a split
wall (water lily sign)
3 (7%)
Type III Fluid collection with septa
(honeycomb sign)
23 (53%)
Type IV Heterogeneous echographic
patterns
10 (22%)
Type V Reflecting thick walls 0 (0%)
Type II-III 2 (4%)
Type I-II-III-IV 1 (2%)
Total 44 (100%)
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developed in one patient after excessive use of 20%
hypertonic saline solution for giant cysts. He was
treated by judicious rehydration. Eight patients devel-
oped biliary leakage and their management is detailed
in the discussion section. Postoperative abscesses and
empyema did not require surgery and were treated
percutaneously.
Discussion
The symptoms of hydatid cysts of the liver depend on
the localization, size, and stage of the cyst. Compli-
cated cysts (free rupture into the intraperitoneal cavity
or biliary tract, or concomitant bacterial infection) are
also symptomatic. Although liver hydatid cysts are
usually asymptomatic, the most common symptoms
are pain and hepatomegaly. Fever and jaundice may
accompany complicated cysts.
Ultrasonography is the primary diagnostic tool
owing to its low cost, and high specificity and
sensitivity. CT, MRI, and MRCP may be used for
better documentation and definition of the vascular/
biliary anatomy. Simple cysts and type 1 hydatid cysts
of the liver are difficult to differentiate using radi-
ologic modalities. Serologic methods may be useful
for the differential diagnoses in difficult cases [2].
Pressure inside the cyst is an important indicator of
its viability and it is usually around 35 cm H2O, which
is generally higher than the intraluminal pressure of
the bile duct. However, this value is much lower in
nonviable cysts. This high pressure is the cause of
communication between cysts and the biliary system
[6]. Jaundice, episodic cholangitis, and elevated liver
function tests are the expected results of biliary
contamination. ERCP and MRCP are not effective
in predicting communication of hydatid cysts with bile
ducts due to intracystic high pressure. However, these
modalities are very sensitive in showing dilated bile
ducts and daughter vesicles or germinative mem-
branes of hydatic cysts in bile ducts [7].
Treatment depends on stage, localization, size, and
complications of the cysts. Chemotherapy should be
the first choice for disseminated disease and for
patients who have a prohibitively high risk for surgery.
Albendazole, an antiparasitic drug, is recommended
as the chemotherapeutic agent of choice. The usual
dosage is 10/15 mg/kg/day [8]. Chemotherapy is
contraindicated in pregnancy due to embryotoxicity
[9]. Franchi and colleagues used 10 mg/kg/day alben-
dazole on 448 patients with uncomplicated hydatid
cyst for 6 months. They found that 74% of the
patients had degeneration in their cysts, and the
persistence rate was 25% at the end of 6 months
[10]. Type I and type II cysts can be treated
successfully and effectively by percutaneous methods.
Although some authors reported a high risk for
peritoneal contamination or anaphylaxis during the
percutaneous procedure, our interventional radiology
team did not experience any such complications
during the same time period in adult patients [11].
Although the technique requires experience, the key
point is to drain the cyst through the hepatic
parenchyme. Surgery is still the first choice for type
III cysts, type IV cysts, and cysts opening into the bile
ducts or peritoneal cavity. There is often no need for
therapy for type V hydatid cysts [12].
Appropriate surgical treatment of hydatid cysts of
the liver depends on communication of the cyst and
the bile duct. If the cyst is localized peripherally, total
cystectomy or hepatic resection is recommended
because of the low rate of recurrence. In accord with
this, in our study, total cystectomy was performed in
three patients at our center with no recurrence.
However, partial cystectomy and omentoplasty are
the most frequently used operations for intraparench-
ymal hydatid cysts. Omentoplasty has been advocated
for its absorptive capacity of residual fluid in the cystic
cavity. It has also been hypothesized to stimulate
macrophage migration into the operated area [13].
Fluid accumulation and recurrence also can be
prevented by using a capitonnage technique, but it is
important to remember that capitonnage carries with
it the risk of injuring major ducts or vessels passing
just outside the pericystic layer. Ariogul and co-
workers have shown that the introflexion method /
suturing the outer surface layers of the cyst to each
other or to the bottom of the cavity to keep the cyst
walls folded [4] / is a simple, safe, and effective
means of closing the cystic cavity. Although pericys-
tectomy and hepatectomy have low recurrence rates,
these operations are very radical and are preferred in
superficial and exophytic hydatid cysts and in cysts
originating from Echinococcus alveolaris .
Patients who have jaundice or a history of cholan-
gitis, elevated liver enzymes, and dilatation or debris
in major bile ducts should be assessed for main bile
duct contamination [14,15]. If the bile ducts are
evaluated with ERCP before surgery, it is not neces-
sary to perform main duct exploration. Kayaalp and
co-workers have shown that hydatid cysts lying
around the hilus of the liver had a higher biliary
Table III. Postoperative complications.
Complications Number (%)
Hypernatremia 1 (2.2%)
Deep venous thrombosis 1 (2.2%)
Cavity abscesses 3 (6.8%)
Urinary infection 1 (2.2%)
Wound infection 4 (9%)
Biliary leakage* 8 (18.2%)
Fistula 3 (6.8%)
Empyema 1 (2.2%)
Diaphragmatic injury 1 (2.2%)
Total 12 (27.3%)$
*Leakage included all patients who had biliary drainage in the
postoperative period. The three patients who were classified as
having fistulas had leakages that continued for /10 days.
$Multiple complications occurred in some patients.
40 A. Ezer et al.
communication rate (48%) than did peripherally
located cysts (27%) [16]. It is still controversial
whether a T-tube or biliary enteric anastomosis is
advantageous after a duct exploration. Alper and
colleagues have shown that choledocoduodenostomy
reduces mortality and morbidity rates compared
with the use of a T-tube for drainage [17]. However,
Erbir and co-workers compared T-tube drainage with
choledochoduodenostomy for mortality and morbid-
ity rates, hospitalization time, and infection rate and
showed superiority of the T-tube [7].
Partial or total cystectomy can be performed
laparoscopically using an umbrella trocar. This
method enables the surgeon evaluating the cystic
cavity to clip and suture the sites of bile duct leakage
[18].
A drain is usually placed to prevent abscess, biloma,
or biliary peritonitis. If bile drainage lasts /10 days, it
should be considered as a biliary fistula. ERCP may
be used successfully to manage these patients with a
low output, that is, B/100 ml/day [16,17,19]. We had
eight patients with bile leakages (18.3%). Leakage
stopped spontaneously in five patients within 7 days;
therefore these were not considered as biliary fistulas
(Table III) [16]. For the remaining three patients,
biliary fistulas were treated by nonsurgical methods. A
nasobiliary catheter was used for the first patient. This
catheter was removed on the 31st postoperative day,
and the fistula closed on the 68th postoperative day. A
biliary stent was placed by ERCP for the second
patient, and the fistula closed on the 16th post-
operative day, and after 20 days the stent was
removed. The fistula of the third patient closed
spontaneously in 10 days. Kayaalp and co-workers
described 14 (26%) biliary leakages in 54 patients that
they have treated. The leakage in nine of the patients
ceased in 7 days, whereas biliary fistulas occurred in
the other five patients. A nasobiliary catheter was used
by ERCP for only two patients, and these fistulas
closed in 2 weeks [20].
Liver hydatid cyst
Gharbie classification
Type V
No treatment
Albendazole 10 mg/kg
(15 days pre-intervention)
Type I and II
Percutaneous
treatment
Type III and IV
Elevated liver enzymes
No
Yes
ERCP/MRCP
Surgery without
bile duct
exploration
Normal
Obstructed
Theurapeutic
ERCP is
successful
Theurapeutic ERCP
is not successful/
possible
Surgery with bile
duct exploration
Figure 1. The suggested algorithm for management of the liver hydatid disease. ERCP, endoscopic retrograde cholangio-pancreatography;
MRCP, magnetic resonance cholangio- pancreatography.
Surgical treatment of liver hydatid cysts 41
Relapse is a major problem in hydatid disease
surgery. Ultrasonography alone is not enough to
detect relapses following surgical treatment of liver
hydatid cyst. Results of an indirect hemagglutination
(IHA) test and an IgE radioallergosorbent test
(RAST) will remain positive long after operation,
and only demonstration of the scolices in the remain-
ing cavity ensures definitive diagnosis [21]. The
recurrence rates of the surgical techniques range
between 0% and 25%, but as yet no prospective
randomized study has shown superiority of one
operative technique over the other [22]. In our center,
the recurrence rate was 9% with a mean follow-up of
11.99/10.8 months.
Conclusion
Cyst size, stage, localization, and relation to the bile
ducts are important in the treatment of liver hydatid
cysts. The aim of surgical intervention is evacuation
and obliteration of the cystic cavity. It is helpful to use
ERCP or MRCP for the appropriate surgical method
in patients with suspected communication with the
biliary system. We use the general algorithm depicted
in Figure 1. Follow-up is usually by US, although
aspiration and cytologic assessment are necessary for
conclusive proof of recurrence.
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